Probable fidaxomicin-induced pancytopenia.
CONCLUSION: A 33-year-old woman developed pancytopenia during a course of fidaxomicin therapy for CDI. Platelet, hemoglobin, and WBC values returned to normal within 3 days of the final fidaxomicin dose.
PMID: 29626003 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Axtell S, Shokoya A, Yocum C Tags: Am J Health Syst Pharm Source Type: research
More News: Chronic Pain | Clostridium Difficile | Drugs & Pharmacology | Endometriosis | Filgrastim | Hepatitis | Hepatitis C | Kidney Stones | Metronidazole | Neulasta | Neupogen | Pain | Pancytopenia | Transplants | Urinary Tract Infections | Xifaxan